← Browse by Condition
Medical Condition

leukemia myeloid acute aml

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT06765876 EARLY_Phase 1
Recruiting

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Enrollment
18 pts
Location
Czechia
Sponsor
Institute of Hematology and Bl...
View Trial →